[1]
2020. Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss Medical Weekly. 150, 1920 (May 2020), w20223. DOI:https://doi.org/10.4414/smw.2020.20223.